These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2227729)
1. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents. Altunkaya D; Smith RN Forensic Sci Int; 1990 Sep; 47(2):113-21. PubMed ID: 2227729 [TBL] [Abstract][Full Text] [Related]
2. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure. Webb KS; Baker PB; Cassells NP; Francis JM; Johnston DE; Lancaster SL; Minty PS; Reed GD; White SA J Forensic Sci; 1996 Nov; 41(6):938-46. PubMed ID: 8914284 [TBL] [Abstract][Full Text] [Related]
3. The development and evaluation of a 125I radioimmunoassay for the measurement of LSD in body fluids. Stead AH; Watton J; Goddard CP; Patel AC; Moffat AC Forensic Sci Int; 1986; 32(1):49-60. PubMed ID: 3770601 [TBL] [Abstract][Full Text] [Related]
4. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples. Wiegand RF; Klette KL; Stout PR; Gehlhausen JM J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010 [TBL] [Abstract][Full Text] [Related]
5. Immunochemical extraction and detection of LSD in whole blood. Kerrigan S; Brooks DE J Immunol Methods; 1999 Apr; 224(1-2):11-8. PubMed ID: 10357201 [TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities. Ratcliffe WA; Fletcher SM; Moffat AC; Ratcliffe JG; Harland WA; Levitt TE Clin Chem; 1977 Feb; 23(2 PT. 1):169-74. PubMed ID: 832379 [TBL] [Abstract][Full Text] [Related]
7. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation. de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700 [TBL] [Abstract][Full Text] [Related]
8. Body fluid levels of lysergide (LSD). Smith RN; Robinson K Forensic Sci Int; 1985 Aug; 28(3-4):229-37. PubMed ID: 4065782 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine. Cassells NP; Craston DH; Hand CW; Baldwin D J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677 [TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood. Sklerov JH; Magluilo J; Shannon KK; Smith ML J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases. Dolder PC; Liechti ME; Rentsch KM Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay for lysergide (LSD) in illicit drugs and biological fluids. Loeffler LJ; Pierce JV J Pharm Sci; 1973 Nov; 62(11):1817-20. PubMed ID: 4758079 [No Abstract] [Full Text] [Related]
13. Analysis of LSD in human body fluids by high-performance liquid chromatography, fluorescence spectroscopy and radioimmunoassay. Twitchett PJ; Fletcher SM; Sullivan AT; Moffat AC J Chromatogr; 1978 Mar; 150(1):73-84. PubMed ID: 641124 [TBL] [Abstract][Full Text] [Related]
14. Gas chromatographic/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples. Musshoff F; Daldrup T Forensic Sci Int; 1997 Aug; 88(2):133-40. PubMed ID: 9251232 [TBL] [Abstract][Full Text] [Related]
15. Confirmation of LSD intoxication by analysis of serum and urine. McCarron MM; Walberg CB; Baselt RC J Anal Toxicol; 1990; 14(3):165-7. PubMed ID: 2374406 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry. Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916 [TBL] [Abstract][Full Text] [Related]
17. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions. Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490 [TBL] [Abstract][Full Text] [Related]
19. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation]. Vu-Duc T; Vernay A; Calanca A Schweiz Med Wochenschr; 1991 Dec; 121(50):1887-90. PubMed ID: 1759150 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial. Dolder PC; Liechti ME; Rentsch KM J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]